Durability of Cognitive Behavioral Therapy Effects for Youth and Adolescents With Anxiety, Depression, or Traumatic Stress:A Meta-Analysis on Long-Term Follow-Ups

Rith-Najarian, Leslie; Mesri, Bita; Park, Alayna L.; Sun, Mo; Chavira, Denise A.; Chorpita, Bruce F.

doi:10.1016/j.beth.2018.05.006

Cited by 46 publications

(27 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, treatment interventions targeting children with diagnosed anxiety disorders show promising long-term results [42,43]. The extent of the EMOTION intervention resembles treatment interventions, and it is possible that this sort of extensiveness is necessary for the successful prevention of anxiety symptoms.…”

Section: Results From Mixed Model Analyses With Masc Child and Parentmentioning

confidence: 99%

See 1 more Smart Citation

A 12-month follow-up of a transdiagnostic indicated prevention of internalizing symptoms in school-aged children: the results from the EMOTION study

Loevaas

Lydersen

Sund

et al. 2020

Child Adolesc Psychiatry Ment Health

View full text Add to dashboard Cite

Background: Anxious and depressive symptoms in youth are highly prevalent, are often comorbid and have a high rate of relapse. Preventive interventions are promising, but follow-up results are lacking. The transdiagnostic EMO-TION program is an indicated preventive cognitive behavioral therapy (CBT) intervention targeting children aged 8-12 years.Methods: The present study investigates the 12 months follow-up effects of the EMOTION intervention in a cluster randomized controlled trial (RCT) with 795 children that included both child self-reports and parental reports.

show abstract

Section: Results From Mixed Model Analyses With Masc Child and Parentmentioning

confidence: 99%

“…To evaluate a true long-term prevention effect, it will be necessary to have a longer follow-up period than 12 months [43].…”

Section: Strengths and Limitationsmentioning

confidence: 99%

A 12-month follow-up of a transdiagnostic indicated prevention of internalizing symptoms in school-aged children: the results from the EMOTION study

Loevaas

Lydersen

Sund

et al. 2020

Child Adolesc Psychiatry Ment Health

View full text Add to dashboard Cite

show abstract

“…Meta-analyses based on multiple RCTs have shown that psychological therapies, particularly cognitive behavioral therapy (CBT), and pharmacological treatments, particularly SSRIs (Ipser, Stein, Hawkridge, & Hoppe, 2009;Walkup et al, 2008), are associated with substantial decreases in anxiety over and above control conditions in the short term. Although findings are somewhat mixed across studies, there is evidence, at least for CBT, for durable changes at longer term followup, and with positive outcomes on broader domains (Gibby, Casline, & Ginsburg, 2017;Kreuze, Pijnenborg, de Jonge, & Nauta, 2018;Reynolds, Wilson, Austin, & Hooper, 2012;Rith-Najarian et al, 2019;Saavedra, Silverman, Morgan-Lopez, & Kurtines, 2010;Swan et al, 2018).…”

Section: Introductionmentioning

confidence: 99%

Research Review: Recommendations for reporting on treatment trials for child and adolescent anxiety disorders – an international consensus statement

Creswell

Nauta

Hudson

et al. 2020

Child Psychology Psychiatry

View full text Add to dashboard Cite

Background: Anxiety disorders in children and young people are common and bring significant personal and societal costs. Over the last two decades, there has been a substantial increase in research evaluating psychological and pharmacological treatments for anxiety disorders in children and young people and exciting and novel research has continued as the field strives to improve efficacy and effectiveness, and accessibility of interventions. This increase in research brings potential to draw together data across studies to compare treatment approaches and advance understanding of what works, how, and for whom. There are challenges to these efforts due largely to variation in studies' outcome measures and variation in the way study characteristics are reported, making it difficult to compare and/or combine studies, and this is likely to lead to faulty conclusions. Studies particularly vary in their reliance on child, parent, and/or assessor-based ratings across a range of outcomes, including remission of anxiety diagnosis, symptom reduction, and other domains of functioning (e.g., family relationships, peer relationships). Methods: To address these challenges, we convened a series of international activities that brought together the views of key stakeholders (i.e., researchers, mental health professionals, young people, parents/caregivers) to develop recommendations for outcome measurement to be used in treatment trials for anxiety disorders in children and young people. Results and Conclusions: This article reports the results of these activities and offers recommendations for selection and reporting of outcome measures to (a) guide future research and (b) improve communication of what has been measured and reported. We offer these recommendations to promote international consistency in trial reporting and to enable the field to take full advantage of the great opportunities that come from data sharing going forward.

show abstract

“…Despite youth being the most common age group for onset of mental disorders, there is less knowledge regarding efficacy and safety of psychotherapies and pharmacological treatments for adolescents experiencing a mental disorder (Crowe & McKay, 2017; Locher et al, 2017; Mychailyszyn & Elson, 2018; Solmi et al, 2020). There are fewer studies conducted in youth samples compared with adults, most existing studies do not assess the long‐term effectiveness of treatments, and generally these studies do not represent real‐world clinical practice (Reynolds et al, 2012; Rith‐Najarian et al, 2019; Weisz et al, 2006). Furthermore, treatment studies in adolescents generally find a smaller effect than those conducted with adults, indicating that treatments may be more effective with adults than adolescents with similar symptoms (Cipriani et al, 2016; Klein et al, 2007; Tsapakis et al, 2008).…”

Section: Introductionmentioning

confidence: 99%

What works for mental health problems in youth? Survey of real‐world experiences of treatments and side effects

Morgan

Ross

Yap

et al. 2020

Early Intervention Psych

View full text Add to dashboard Cite

Aim Despite youth being the most common age group for onset of mental disorders, there is less knowledge on the benefits and harms of treatments in young people. In addition, efficacy data from randomized controlled trials may not generalize to how treatment works outside of research settings. This study aimed to investigate young people's perceived effectiveness of different treatments for mental health problems, the professionals who delivered these, and the experience of negative effects. Methods We developed a consumer report website where young people who were ever diagnosed with a mental disorder provided ratings on the helpfulness or harmfulness of different types of professionals, mental health treatments (medical, psychological complementary/alternative) and self‐help strategies, and whether they had experienced particular negative effects. Results Here, 557 young people aged 12–25 years, who were recruited from English‐speaking, high‐income countries, provided 1258 ratings of treatments. All treatments showed varied perceptions of effectiveness. Medical and psychological treatments were rated moderately helpful on average with low rates of harmfulness. Self‐help strategies were rated as being as helpful as professional treatments. Side effects related to the head or mind (e.g., concentration difficulties, inability to feel emotions, depression and irritability) were the most common across all types of medicines. For psychological treatments, treatment being too expensive and feeling worse at the end of a session were the most commonly reported negative effects. Conclusions Study findings may be a useful guide to clinicians, researchers, young people and their families about what is likely to work in real‐world settings.

show abstract

Durability of Cognitive Behavioral Therapy Effects for Youth and Adolescents With Anxiety, Depression, or Traumatic Stress:A Meta-Analysis on Long-Term Follow-Ups

Cited by 46 publications

References 44 publications

A 12-month follow-up of a transdiagnostic indicated prevention of internalizing symptoms in school-aged children: the results from the EMOTION study

A 12-month follow-up of a transdiagnostic indicated prevention of internalizing symptoms in school-aged children: the results from the EMOTION study

Research Review: Recommendations for reporting on treatment trials for child and adolescent anxiety disorders – an international consensus statement

What works for mental health problems in youth? Survey of real‐world experiences of treatments and side effects

Contact Info

Product

Resources

About